Nicole Burns
Finance & Accounting Professional
Granger
Summary
Results-driven finance leader with expertise in FP&A, Accounting, and Treasury. Skilled in team leadership, financial strategy, and data-driven decision-making to optimize performance. Adept at cash flow management, budgeting, forecasting, and risk mitigation to ensure stability and growth. Strong problem solver and collaborator, streamlining processes, enhancing efficiency, and implementing financial controls to drive profitability and long-term success.
Overview
16
16
years of professional experience
2009
2009
years of post-secondary education
Work History
Director, Financial Planning & Analysis and Controller
The Mom Project
06.2022 - Current
- Built FP&A function at TMP ($88M Revenue in 2022)
- Supported the company through lowest cash balance of $950k; less than 1 week of cash
- Drove $32M opex savings across the company including:
- Eight reductions in force, cut over 85% of workforce
- Targeted marketing and ad spend reduction driven by data and outcomes
- Prioritization of IT tech stack
- Accounting savings through identifying new Merchant Service Provider (saving $200k+/yr) and new EOR (driving efficiencies and savings ~$50k/yr)
- Developed new reporting including Weekly Flash, near-term Cash Forecast, and KPI reporting
Senior Manager, Corporate and G&A FP&A
Horizon Therapeutics
01.2019 - 05.2022
- Financial and business support for G&A function representing $350.0M in expenses while also managing total Corporate consolidation of P&L, Cash Flow, Balance Sheet, and Board Materials for a +$3.0B in sales company
- Automated Cash Flow calculations with implementation of new system and support from Financial Systems
- Scenario modeling for Cash Flow for a potential $3.0B acquisition during a product supply shortage due to pandemic vaccine priority
- Developed extended LRP (15 years) as defense model/valuations ahead of future acquisition by Amgen in 2023; a $27.8B deal
Senior Manager, Americas Region Support
Baxter International Inc.
01.2018 - 01.2019
- Financial and business support of the Americas region representing $6.0B in sales
- Improved forecast accuracy for Cash Flow around $2.5B
Manager, Global Planning
Baxter International Inc.
01.2016 - 01.2018
- Owner of the Total Shareholder Return (TSR) model which helped Baxter outperform in 2016 with 4% YoY growth through the following:
- Strategy/Operational Performance: sales growth, positive mix/improved pricing, OPEX savings realized
- Capital Market Management: exceeded consensus estimates all four quarters, clear buy-in to the margin expansion story for current and future years
- Balance Sheet Management/Capital Deployment: $5B debt reduction and pension funding, working capital programs drove ~$200M cash generation, ~3x improvement in Free Cash Flow (FCF), increased annual dividend by ~13%
- Independently managed Total Baxter Profitability Model for 25+ identified businesses, allocating all costs back to the businesses/regions
- Supported Baxter Transformation Office (BTO) in efforts to identify, implement and track progress driving savings across Baxter through smarter spend, simplification and cultural transformations; On track to deliver over $1B in savings by 2021 with over $800M savings in 2017 versus 2015 baseline
Senior Financial Analyst, Integrated Pharmacy Solutions Franchise
Baxter International Inc.
01.2015 - 12.2015
- Led financial support for the $2.3B Global Integrated Pharmacy Solutions Franchise
- Created P&L Profitability Analysis for the IPS Product Therapy Teams which led to the identification of:
- Pricing strategies: DoseEdge, change from per dose pricing strategy to a licensing strategy; Orals and Enteral Systems, we were selling these products for less than the total cost to manufacture so we aligned focus on this portfolio to work on pricing; ultimately ended DoseEdge in 2018
- Code Optimization: IPA alone has over 730 individual codes/SKUs and reduced those by over 50% driving efficiency, improved product quality and availability
- Cost Reduction: Global Bag Strategy – the bags we were manufacturing in our Grasslands, CO facility could be made at a significantly lower price at other plants with $11M savings
Senior Financial Analyst, Baxter Gambro Renal, Americas Finance
Baxter International Inc.
01.2014 - 12.2014
- Integration Project Lead responsible for the integration of FP&A processes and conversion of internal controls to be SOX compliant for $3.9B Gambro acquisition
Senior Financial Analyst, Global Fluid Systems Franchise
Baxter International Inc.
01.2012 - 12.2013
- Managed Colleague Reserve ($1B reserve)
- Assisted with the implementation of PlanIT and BaxIntel
Financial Analyst, Corporate Controller’s Group
Baxter International Inc.
01.2012 - 12.2012
Financial Analyst, Global Supply Chain Finance
Baxter International Inc.
01.2011 - 12.2012
- Assisted with implementation of new ERP system JDE 8.12
Financial Analyst, Europe Manufacturing Finance
Baxter International Inc.
01.2010 - 12.2011
- Team leader for AIDA Optimization project; saved 300+ hours during budget process; was 85% higher than project goal
- Reviewed and submitted capital project approvals; updated and maintained KPIs of Lessines manufactured products
Financial Analyst, BioScience Vaccines & Regenerative Medicine
Baxter International Inc.
01.2009 - 12.2010
Education
Bachelor of Business Administration - Finance (with honors)
University of Notre Dame
Notre Dame, INSkills
- Strategic Decision-Making
- Leadership & Team Management
- Communication & Stakeholder management
- Problem-Solving & Critical Thinking
- Attention to Detail
- Budgeting & Forecasting
- Financial Analysis & Modeling
- Financial Reporting & Accounting
- Accounts Receivable (AP), Accounts Payable (AP), Payroll and General Ledger (GL)
- Data Analytics & BI Tools (Power BI, Tableau, SQL)
- Treasury Management
- ERP Systems (SAP, Oracle, Workday)
- Accounting Software (Quickbooks)
Timeline
Director, Financial Planning & Analysis and Controller
The Mom Project
06.2022 - Current
Senior Manager, Corporate and G&A FP&A
Horizon Therapeutics
01.2019 - 05.2022
Senior Manager, Americas Region Support
Baxter International Inc.
01.2018 - 01.2019
Manager, Global Planning
Baxter International Inc.
01.2016 - 01.2018
Senior Financial Analyst, Integrated Pharmacy Solutions Franchise
Baxter International Inc.
01.2015 - 12.2015
Senior Financial Analyst, Baxter Gambro Renal, Americas Finance
Baxter International Inc.
01.2014 - 12.2014
Senior Financial Analyst, Global Fluid Systems Franchise
Baxter International Inc.
01.2012 - 12.2013
Financial Analyst, Corporate Controller’s Group
Baxter International Inc.
01.2012 - 12.2012
Financial Analyst, Global Supply Chain Finance
Baxter International Inc.
01.2011 - 12.2012
Financial Analyst, Europe Manufacturing Finance
Baxter International Inc.
01.2010 - 12.2011
Financial Analyst, BioScience Vaccines & Regenerative Medicine
Baxter International Inc.
01.2009 - 12.2010
Bachelor of Business Administration - Finance (with honors)
University of Notre Dame
Similar Profiles
Kate AdamsKate Adams
Director, Finance Operations at The Mom ProjectDirector, Finance Operations at The Mom Project
Paulo SousaPaulo Sousa
Senior Software Engineer at The Mom ProjectSenior Software Engineer at The Mom Project
Suzanne ReedSuzanne Reed
Senior Recruiter and Manager, Talent Success at The Mom ProjectSenior Recruiter and Manager, Talent Success at The Mom Project